Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-22 Sale |
2021-03-24 5:25 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
54,729 | $46.32 | $2,535,226 | 533,218 (Indirect Direct) |
View |
| 2021-03-03 Sale |
2021-03-05 7:04 pm |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
100,000 | $44.78 | $4,478,450 | 250,390 (Indirect Direct) |
View |
| 2021-03-02 Sale |
2021-03-04 7:03 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
125,000 | $46.94 | $5,867,148 | 576,960 (Indirect Direct) |
View |
| 2021-03-02 Sale |
2021-03-04 7:02 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
100,000 | $46.92 | $4,692,158 | 325,030 (Indirect) |
View |
| 2021-03-02 Sale |
2021-03-04 7:00 pm |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
100,000 | $46.94 | $4,694,090 | 350,390 (Indirect Direct) |
View |
| 2021-02-25 Purchase |
2021-02-26 7:46 pm |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
25,700 | $46.83 | $1,203,480 | 34,413 (Indirect Direct) |
View |
| 2020-12-17 Sale |
2020-12-18 2:36 pm |
Royalty Pharma plc | RPRX | ADAGE CAPITAL PARTNERS GP L.L.C. Adage Capital Partners L.P. Adage Capital Advisors L.L.C. Atchinson Robert Gross Phillip 10% Owner |
7,301,050 | $43.92 | $320,672,221 | 38,714,280 (Indirect) |
View |
| 2020-10-20 Sale(A) |
2020-10-23 7:11 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
463,200 | $42 | $19,454,400 | 0 (Direct) |
View |
| 2020-10-20 Sale |
2020-10-22 9:48 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
463,200 | $42 | $19,454,400 | 895,837 (Indirect Direct) |
View |
| 2020-06-18 Purchase |
2020-06-23 9:21 pm |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
2,950 | $28 | $82,600 | 797,705 (Indirect Direct) |
View |
| 2020-06-18 Purchase |
2020-06-23 9:14 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
15,000 | $28 | $420,000 | 1,556,624 (Indirect Direct) |
View |
| 2020-06-18 Purchase |
2020-06-23 9:13 pm |
Royalty Pharma plc | RPRX | Hite Christopher EVP & Vice Chairman |
70,000 | $28 | $1,960,000 | 248,600 (Direct) |
View |
| 2020-06-18 Purchase |
2020-06-22 9:55 pm |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
20,000 | $28 | $560,000 | 7,885,433 (Indirect) |
View |
| 2020-06-18 Purchase |
2020-06-22 9:55 pm |
Royalty Pharma plc | RPRX | FORD WILLIAM E Director |
1,500,000 | $28 | $42,000,000 | 4,414,862 (Indirect) |
View |
| 2020-06-18 Purchase |
2020-06-22 9:54 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
14,200 | $28 | $397,600 | 1,348,411 (Indirect Direct) |
View |
| 2020-06-18 Purchase |
2020-06-22 9:47 pm |
Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Nogra Group SICAF SIF MGG Strategic Nogra Group SICAF SIF GG Strategic Director 10% Owner |
50,000 | $28 | $1,400,000 | 1,812,389 (Indirect) |
View |
| 2020-06-18 Purchase |
2020-06-22 5:31 pm |
Royalty Pharma plc | RPRX | ADAGE CAPITAL PARTNERS GP L.L.C. Adage Capital Partners L.P. Adage Capital Advisors L.L.C. Atchinson Robert Gross Phillip 10% Owner |
3,000,000 | $28 | $84,000,000 | 46,350,843 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-10-20 Conversion |
2021-02-26 7:44 pm |
N/A N/A |
Royalty Pharma plc | RPRX | FORD WILLIAM E Director |
640,057 | $0 | 4,731,851 (Indirect) |
View |
| 2020-12-16 Other |
2021-02-26 7:44 pm |
N/A N/A |
Royalty Pharma plc | RPRX | FORD WILLIAM E Director |
42,101 | $0 | 4,731,851 (Indirect) |
View |
| 2020-06-18 Conversion(A) |
2021-02-26 7:41 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
6,270,088 | $0 | 1,113,010 (Indirect) |
View |
| 2020-12-31 Conversion |
2021-01-05 9:53 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
440,000 | $0 | 827,636 (Indirect) |
View |
| 2020-06-18 Conversion(A) |
2021-01-05 9:51 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
26,587 | $0 | 26,963 (Indirect) |
View |
| 2020-06-15 Option Award(A) |
2021-01-05 9:51 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
2,605 | $0 | 26,963 (Indirect) |
View |
| 2020-12-31 Conversion |
2021-01-05 9:45 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
440,000 | $0 | 1,045,615 (Indirect) |
View |
| 2020-12-31 Conversion |
2021-01-05 9:43 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
550,000 | $0 | 1,315,035 (Indirect) |
View |
| 2020-12-31 Option Award |
2021-01-04 8:04 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
820 | $45.69 | 8,713 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-04 8:02 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
820 | $45.69 | 14,367 (Direct) |
View |
Ownership |
2020-12-31 8:43 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Urist Marshall EVP & Co-Head Research & Inv. |
0 | $0 | 1,638,060 (Indirect) |
View |
| 2020-10-20 Conversion |
2020-10-22 9:48 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
509,520 | $0 | 895,837 (Direct) |
View |
| 2020-09-30 Option Award |
2020-10-02 7:09 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
613 | $41.17 | 7,893 (Direct) |
View |
| 2020-09-30 Option Award |
2020-10-02 7:08 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Engelbert Catherine M. Director |
910 | $41.17 | 13,410 (Direct) |
View |
| 2020-09-30 Option Award |
2020-10-02 7:07 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
910 | $41.17 | 13,547 (Direct) |
View |
| 2020-06-18 Option Award |
2020-09-23 8:29 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Engelbert Catherine M. Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2020-06-18 Option Award |
2020-09-23 8:26 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
12,500 | $0 | 12,637 (Direct) |
View |
| 2020-06-30 Option Award |
2020-09-23 8:26 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
137 | $48 | 12,637 (Direct) |
View |
| 2020-08-13 Option Award |
2020-08-17 8:42 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
7,280 | $0 | 7,280 (Direct) |
View |
| 2020-08-13 Option Award |
2020-08-17 8:40 pm |
N/A N/A |
Royalty Pharma plc | RPRX | LOVE TED W Director |
7,280 | $0 | 17,280 (Direct) |
View |
Ownership |
2020-08-10 9:56 pm |
N/A N/A |
Royalty Pharma plc | RPRX | LOVE TED W Director |
0 | $0 | 10,000 (Direct) |
View |
Ownership |
2020-08-10 9:27 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
0 | $0 | 419,480 (Direct) |
View |
| 2020-06-18 Conversion |
2020-06-23 9:21 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
25,597 | $0 | 797,705 (Indirect) |
View |
| 2020-06-15 Option Award |
2020-06-23 9:21 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
772,754 | $0 | 797,705 (Indirect) |
View |
| 2020-06-15 Option Award |
2020-06-23 9:14 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
1,541,624 | $0 | 1,556,624 (Direct) |
View |
| 2020-06-15 Option Award |
2020-06-23 9:13 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Hite Christopher EVP & Vice Chairman |
178,600 | $0 | 248,600 (Direct) |
View |
| 2020-06-18 Conversion |
2020-06-22 9:55 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
265,991 | $0 | 7,885,433 (Indirect) |
View |
| 2020-06-15 Option Award |
2020-06-22 9:55 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
7,765,047 | $0 | 7,885,433 (Indirect) |
View |
| 2020-06-15 Option Award |
2020-06-22 9:55 pm |
N/A N/A |
Royalty Pharma plc | RPRX | FORD WILLIAM E Director |
2,914,862 | $0 | 4,414,862 (Indirect) |
View |
| 2020-06-18 Conversion |
2020-06-22 9:54 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
289,036 | $0 | 1,348,411 (Indirect) |
View |
| 2020-06-15 Option Award |
2020-06-22 9:54 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
1,069,401 | $0 | 1,348,411 (Direct) |
View |
| 2020-06-18 Conversion |
2020-06-22 9:47 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Nogra Group SICAF SIF MGG Strategic Nogra Group SICAF SIF GG Strategic Director 10% Owner |
64,758,912 | $0 | 1,812,389 (Indirect) |
View |
| 2020-06-15 Option Award |
2020-06-22 9:47 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Nogra Group SICAF SIF MGG Strategic Nogra Group SICAF SIF GG Strategic Director 10% Owner |
1,328,298 | $0 | 1,812,389 (Indirect) |
View |
| 2020-06-18 Conversion |
2020-06-22 5:31 pm |
N/A N/A |
Royalty Pharma plc | RPRX | ADAGE CAPITAL PARTNERS GP L.L.C. Adage Capital Partners L.P. Adage Capital Advisors L.L.C. Atchinson Robert Gross Phillip 10% Owner |
47,652,376 | $0 | 46,350,843 (Indirect) |
View |